Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 3
1953 4
1954 3
1955 3
1956 4
1957 5
1958 2
1959 1
1960 1
1961 3
1962 1
1963 5
1964 7
1965 2
1966 7
1967 9
1968 12
1969 6
1970 10
1971 7
1972 9
1973 7
1974 9
1975 11
1976 8
1977 4
1978 11
1979 15
1980 20
1981 19
1982 11
1983 16
1984 17
1985 13
1986 17
1987 22
1988 29
1989 36
1990 20
1991 28
1992 36
1993 21
1994 21
1995 43
1996 40
1997 34
1998 39
1999 41
2000 40
2001 37
2002 31
2003 26
2004 34
2005 36
2006 34
2007 28
2008 35
2009 33
2010 62
2011 73
2012 72
2013 82
2014 81
2015 76
2016 98
2017 102
2018 96
2019 96
2020 111
2021 121
2022 101
2023 102
2024 43

Text availability

Article attribute

Article type

Publication date

Search Results

2,107 results

Results by year

Filters applied: . Clear all
Page 1
CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T, Yakoub MA, Chandler A, Christ AB, Yang G, Ouerfelli O, Rajasekhar VK, Yoshida A, Kondo H, Hata T, Tazawa H, Dogan Y, Moore MAS, Fujiwara T, Ozaki T, Purdue E, Healey JH. Fujiwara T, et al. Among authors: hata t. Mol Cancer Ther. 2021 Aug;20(8):1388-1399. doi: 10.1158/1535-7163.MCT-20-0591. Epub 2021 Jun 4. Mol Cancer Ther. 2021. PMID: 34088832 Free PMC article.
Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Sugiura I, Doki N, Hata T, Cho R, Ito T, Suehiro Y, Tanaka M, Kako S, Matsuda M, Yokoyama H, Ishikawa Y, Taniguchi Y, Hagihara M, Ozawa Y, Ueda Y, Hirano D, Sakura T, Tsuji M, Kamae T, Fujita H, Hiramoto N, Onoda M, Fujisawa S, Hatta Y, Dobashi N, Nishiwaki S, Atsuta Y, Kobayashi Y, Hayakawa F, Ohtake S, Naoe T, Miyazaki Y. Sugiura I, et al. Among authors: hata t. Blood Adv. 2022 Jan 25;6(2):624-636. doi: 10.1182/bloodadvances.2021004607. Blood Adv. 2022. PMID: 34516628 Free PMC article. Clinical Trial.
Author's reply.
Hata T, Kato K, Kamiya K, Okuyama Y, Fujii Y, Yagi N, Ozawa T, Nakagawa Y. Hata T, et al. Intern Med. 2024 Jan 2. doi: 10.2169/internalmedicine.3218-23. Online ahead of print. Intern Med. 2024. PMID: 38171862 Free article. No abstract available.
Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial.
Nakatsuji T, Hata TR, Tong Y, Cheng JY, Shafiq F, Butcher AM, Salem SS, Brinton SL, Rudman Spergel AK, Johnson K, Jepson B, Calatroni A, David G, Ramirez-Gama M, Taylor P, Leung DYM, Gallo RL. Nakatsuji T, et al. Among authors: hata tr. Nat Med. 2021 Apr;27(4):700-709. doi: 10.1038/s41591-021-01256-2. Epub 2021 Feb 22. Nat Med. 2021. PMID: 33619370 Free PMC article. Clinical Trial.
Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment.
Simpson EL, Schlievert PM, Yoshida T, Lussier S, Boguniewicz M, Hata T, Fuxench Z, De Benedetto A, Ong PY, Ko J, Calatroni A, Rudman Spergel AK, Plaut M, Quataert SA, Kilgore SH, Peterson L, Gill AL, David G, Mosmann T, Gill SR, Leung DYM, Beck LA. Simpson EL, et al. Among authors: hata t. J Allergy Clin Immunol. 2023 Nov;152(5):1179-1195. doi: 10.1016/j.jaci.2023.05.026. Epub 2023 Jun 13. J Allergy Clin Immunol. 2023. PMID: 37315812 Free article. Clinical Trial.
Cancer-specific tissue-resident memory T-cells express ZNF683 in colorectal cancer.
Kitakaze M, Uemura M, Hara T, Chijimatsu R, Motooka D, Hirai T, Konno M, Okuzaki D, Sekido Y, Hata T, Ogino T, Takahashi H, Miyoshi N, Ofusa K, Mizushima T, Eguchi H, Doki Y, Ishii H. Kitakaze M, et al. Among authors: hata t. Br J Cancer. 2023 May;128(10):1828-1837. doi: 10.1038/s41416-023-02202-4. Epub 2023 Mar 3. Br J Cancer. 2023. PMID: 36869093 Free PMC article.
Role of Tumor-Associated Macrophages in Sarcomas.
Fujiwara T, Healey J, Ogura K, Yoshida A, Kondo H, Hata T, Kure M, Tazawa H, Nakata E, Kunisada T, Fujiwara T, Ozaki T. Fujiwara T, et al. Among authors: hata t. Cancers (Basel). 2021 Mar 3;13(5):1086. doi: 10.3390/cancers13051086. Cancers (Basel). 2021. PMID: 33802565 Free PMC article. Review.
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer.
Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Yasumizu Y, et al. Among authors: hata t. Nat Commun. 2020 Jan 17;11(1):338. doi: 10.1038/s41467-019-14219-6. Nat Commun. 2020. PMID: 31953400 Free PMC article.
2,107 results